VVOS
VVOS
NASDAQ · Health Care

Vivos Therapeutics Inc

$0.45
-0.04 (-7.81%)
As of Jun 30, 10:50 PM ET ·
Financial Highlights (FY 2026)
Revenue
22.87M
Net Income
-27,754,569
Gross Margin
60.4%
Profit Margin
-121.4%
Rev Growth
+2.9%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 60.4% 60.4% 46.4% 46.4%
Operating Margin -114.0% -102.6% 21.5% 19.1%
Profit Margin -121.4% -115.3% 15.3% 15.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 22.87M 22.23M 4.42M 4.57M
Gross Profit 13.82M 13.43M 2.05M 2.12M
Operating Income -26,080,901 -22,815,718 949.1K 872.8K
Net Income -27,754,569 -24,279,852 675.6K 727.9K
Gross Margin 60.4% 60.4% 46.4% 46.4%
Operating Margin -114.0% -102.6% 21.5% 19.1%
Profit Margin -121.4% -115.3% 15.3% 15.9%
Rev Growth +2.9% +2.9% +3.6% -1.9%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 6.54M 5.85M
Total Equity 8.58M 7.69M
D/E Ratio 0.76 0.76
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -24,365,726 -22,499,455 1.16M 1.26M
Free Cash Flow 869.0K 665.9K